GENOMIC ANALYSIS AS THE FIRST STEP TOWARD PERSONALIZED TREATMENT IN RENAL CELL CARCINOMA
Renal cell carcinoma (RCC) drug resistance mechanisms still remain elusive. Although most patients initially respond to targeted therapy (i.e. to tyrosine kinase inhibitors), acquired resistance can still eventually develop. Most of the patients suffer from intrinsic (primary) resistance as well, su...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2014-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00194/full |